Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» The price is right for patient-switching on Biogen's new hemophilia med Alprolix
The price is right for patient-switching on Biogen's new hemophilia med Alprolix
The price is right for patient-switching on Biogen's new hemophilia med Alprolix
Submitted by
admin
on April 22, 2014 - 9:30am
Source:
Fierce Pharma
News Tags:
Biogen Idec
hemophilia B
drug pricing
Alprolix
Headline:
The price is right for patient-switching on Biogen's new hemophilia med Alprolix
Do Not Allow Advertisers to Use My Personal information
